tommythecat
New member
תוספי אנטי-אוקסידנטים ותמותה
מצ"ב התקציר הבא מהמגזין היוקרתי JAMA. עד שאני אקרא את המחקר המלא, אני לא יכול להתייחס למאמר עצמו, אבל זה המקום להזכיר שאני מתריע זה זמן רב בדיוק מפני בטא קרוטן ו"ויטמין E" כחלק מהביקורת הכללית שלי על מולטי-ויטמינים. יוסי
מצ"ב התקציר הבא מהמגזין היוקרתי JAMA. עד שאני אקרא את המחקר המלא, אני לא יכול להתייחס למאמר עצמו, אבל זה המקום להזכיר שאני מתריע זה זמן רב בדיוק מפני בטא קרוטן ו"ויטמין E" כחלק מהביקורת הכללית שלי על מולטי-ויטמינים. יוסי
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention Systematic Review and Meta-analysis Goran Bjelakovic, MD, DrMedSci; Dimitrinka Nikolova, MA; Lise Lotte Gluud, MD, DrMedSci; Rosa G. Simonetti, MD; Christian Gluud, MD, DrMedSci JAMA. 2007;297:842-857. Context Antioxidant supplements are used for prevention of several diseases. Objective To assess the effect of antioxidant supplements on mortality in randomized primary and secondary prevention trials. Data Sources and Trial Selection We searched electronic databases and bibliographies published by October 2005. All randomized trials involving adults comparing beta carotene, vitamin A, vitamin C (ascorbic acid), vitamin E, and selenium either singly or combined vs placebo or vs no intervention were included in our analysis. Randomization, blinding, and follow-up were considered markers of bias in the included trials. The effect of antioxidant supplements on all-cause mortality was analyzed with random-effects meta-analyses and reported as relative risk (RR) with 95% confidence intervals (CIs). Meta-regression was used to assess the effect of covariates across the trials. Data Extraction We included 68 randomized trials with 232 606 participants (385 publications). Data Synthesis When all low- and high-bias risk trials of antioxidant supplements were pooled together there was no significant effect on mortality (RR, 1.02; 95% CI, 0.98-1.06). Multivariate meta-regression analyses showed that low-bias risk trials (RR, 1.16; 95% CI, 1.05-1.29) and selenium (RR, 0.998; 95% CI, 0.997-0.9995) were significantly associated with mortality. In 47 low-bias trials with 180 938 participants, the antioxidant supplements significantly increased mortality (RR, 1.05; 95% CI, 1.02-1.08). In low-bias risk trials, after exclusion of selenium trials, beta carotene (RR, 1.07; 95% CI, 1.02-1.11), vitamin A (RR, 1.16; 95% CI, 1.10-1.24), and vitamin E (RR, 1.04; 95% CI, 1.01-1.07), singly or combined, significantly increased mortality. Vitamin C and selenium had no significant effect on mortality. Conclusions Treatment with beta carotene, vitamin A, and vitamin E may increase mortality. The potential roles of vitamin C and selenium on mortality need further study.